Abstract:Background: Conventional cytogenetics only analyzes metaphase cells and this analysis is affected by chromosome number and quality. A large mass of metaphase or interphase cells can be detected by fluorescence in situ hybridization on chromatosome and bone marrow smears to examine the number and structure of chromatosome. Objective: To test chromosome abnormality by fluorescence in situ hybridization and compare with the results from conventional cytogenetic analysis (CCA) in myelodysplastic syndrome (MDS). Design, Time and Setting: A case analysis was conducted at the Shenzhen Hospital of Peking University from August 2006 to September 2007. Participants: Forty-eight MDS patients, who had been preliminarily diagnosed according to FAB criteria, followed up and received chromatosome examination, were enrolled at the Shenzhen Hospital of Peking University. Simultaneously, five iron deficiency anemia patients were included as controls. Bicolor probe and CEP8 SpectumAqua probe were purchased from Vysis. Methods: Bone marrow samples received CCA by R differential staining technique. Slide was prepared by direct or short-term culture method, at least 20 karyotypes in each sample. Remaining samples received fluorescence in situ hybridization. Using airdrying, fluid was prepared at the ratio of 1:2:7 (probe: water: hybrid buffer solution), dropped in the hybrid region of the slide. Red/green fluorescence hybrid signal of interphase cells were observed under a fluorescent microscope and color filter glass, 200 in each sample. Main Outcome Measures: Abnormal positive rate of bone marrow cells was measured by two techniques. Results: Of 48 MDS patients, 38 survived after 24 months of follow-up. Using CCA, karyotype abnormalities were found in 18 (37.5%) of 48 cases, among which complex karyotypes were found in 4 (8.3%) cases, a deletion of chromosome 5/a deletion of the long arm of chromosome 5 (-5/5q-) in 5 (10.4%) cases, -7/7q- in 5 (10.4%) cases, trisomy 8 in 8 (16.6%) cases, 20q- in 2 (4.6%) cases, unconsistent translocations in 3 (6.2%) cases. Fluorescence in situ hybridization detected 5q- in 2 additional cases, 7q- in 5 additional cases, -7 in 1 additional case, +8 in 12 addition cases in addition to confirming -5/5q-, -7/7q- and +8 found by CCA in 5, 5, 8 cases raising the detection rates of -5/5q-, -7nq- and +8 to 14.5%, 22.9% and 41.7%, respectively. Conclusion: The fluorescence in situ hybridization with panel probes is more sensitive and specific for detection of chromosome 5, 7, 8 abnormalities in MDS patients than that of CCA. But it cannot replace CCA, because it cannot detect the chromosome translocation. This indicates that their combination can increase the positive rate of chromosome abnormality in MDS patients.

Detecting the abnormity of chromosomes 8 and 20 aberrations in myelodysplastic syndromes by using fluorescence in situ hybridization

Chromosomes 5, 7 and 8 abnormalities in myelodysplastic syndromes by using interphase fluorescence in situ hybridization

Detection of Chromosomes 5 and 7 Aberrations in Myelodysplastic Syndromes Using Dual-Color Fluorescence in Situ Hybridization

Analysis of the Karyotype Abnormalities and Its Prognostic in 298 Patients with Myelodysplastic Syndrome

[Karyotype Analysis of 283 Cases of Myelodysplastic Syndrome].

Clinical Significance of Cytogenetic and Molecular Genetic Abnormalities in 634 Chinese Patients with Myelodysplastic Syndromes

[Cytogenetic Analysis on 135 Cases of Chronic Myelogenous Leukemias with Non-Simple Philadelphia Chromosome].

[A comparative study of fluorescence in situ hybridization versus conventional cytogenetics in the detection of clonal aberrations in myelodysplastic syndrome].

Multiplex Fluorescence in Situ Hybridization (M-FISH) in the Detection of Complex Karyotypic Abnormalities of Acute Myeloid Leukemia and Myelodysplastic Syndromes.

Standardized fluorescence in situ hybridization testing based on an appropriate panel of probes more effectively identifies common cytogenetic abnormalities in myelodysplastic syndromes than conventional cytogenetic analysis: a multicenter prospective study of 2302 patients in China.

Prognostic Power of Abnormal Cytogenetics for Multiple Myeloma: a Multicenter Study in China.

Multiplex Ligation-Dependent Probe Amplification Identifies Copy Number Changes in Normal and Undetectable Karyotype MDS Patients

[Identification of Complex Chromosomal Aberrations in Acute Leukemia by Using Conventional Cytogenetics Combined with Multiplex Fluorescence in Situ Hybridization].

The prevalence of chromosomal aberrations associated with myelodysplastic syndromes in China

[Fluorescence in Situ Hybridization Identifies Complex Chromosomal Aberrations in Multiple Myeloma].

Combining metaphase cytogenetics with single nucleotide polymorphism arrays can improve the diagnostic yield and identify prognosis more precisely in myelodysplastic syndromes

Detection of Abnormal Numbers of Chromosome 8 with Interphase Fluorescence in Situ Hybridization in Hematologic Malignancies

Fluorescence in Situ Hybridization Analysis of Chromosome Aberrations in 60 Chinese Patients with Multiple Myeloma

Study on Chromosomal Aberrations in Patients with Multiple Myeloma by Fluorescence in Situhybridization

[M-FISH Technique in Diagnosis and Prognostic Analysis for Acute Leukemia with Complex Chromosomal Aberrations].

Cytogenetic Abnormalities of 50 MDS Patients by FISH Detection and Conventional Karyotype Analysis